Zenas BioPharma (ZBIO) stock plunges as the company posts late-stage trial data for its lead asset, obexelimab, in ...
Argenx has announced that the US Food and Drug Administration has accepted for priority review a supplemental biologics ...
Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...
AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving ...
In 20th-century biochemistry history of China, Szu-Chih Liu (刘思职, 1904—1983)(Fig. 1) acted as a central bridge in both academic genealogy and knowledge indigenization. Liu inherited the methodology ...
FDA grants Priority Review to sBLA for efgartigimod alfa-fcab for adults with AChR-Ab seronegative generalized myasthenia gravis.
TROPION-Lung17 will enroll approximately 400 patients across global sites. Participants are randomized 1:1 to receive either ...
Samsung Bioepis pursues direct sales by weighing Organon acquisition to boost profits Samsung Bioepis weighs buying Organon ...
Structural alignment in fibrous tissues like myocardium and tendons is a key biomarker of physiological integrity and ...
Active TED patients showed higher thyrotropin receptor antibody levels and increased DCP vessel density.
MISSISSAUGA, ON / ACCESS Newswire / January 9, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback